Results 11 to 20 of about 3,391 (207)

„Cognitive Enhancement" or non-evidence-based nootropic abuse? – Use of Piracetam in Hungary

open access: yesCardiologia Hungarica
Piracetam has been available on the market since 1971. Its primary indication is the age-related memory decline. The objective of this review is to highlight the controversies surrounding in the use of piracetam.
András Érszegi   +4 more
doaj   +2 more sources

Synergistic neurotrophic effects of piracetam and thiotriazoline

open access: yesНеврология, нейропсихиатрия, психосоматика, 2016
The paper considers the synergy between the nootropic drug piracetam and the metabolic agent thiotriazoline that maintains energy metabolism and survival of neurons and other types of cells. Piracetam, a nootropic drug, a chemical pyrrolidone derivative,
O. A. Gromova   +3 more
doaj   +3 more sources

Piracetam potentiates neuronal and behavioral effects of ketamine [PDF]

open access: yesResearch Results in Pharmacology, 2019
Introduction: Ketamine has a fast, but short-term antidepressant effect. To support the therapeutic effect, repeated administrations of the drug are needed, which causes cognitive disorders.
Igor I. Abramets   +3 more
doaj   +5 more sources

Comparative pharmacokinetics and pharmacodinamics of noopept, its activity metabolite cycloprolylglycine and piracetam

open access: yesФармакокинетика и Фармакодинамика, 2019
While studing of experimental pharmacokinetics of the peptide analogues piracetam noopept - N-phenylacetyl-L-prolyl-glycine ethyl ester, was found the active metabolite that identificated as cyclo-L-prolylglycine (CPG).
Svetlana Boyko   +2 more
doaj   +3 more sources

Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam

open access: yesFrontiers in Neuroscience, 2010
Piracetam, the prototype of the so-called nootropic drugs’ is used since many years in different countries to treat cognitive impairment in aging and dementia.
Kristina Leuner   +4 more
doaj   +2 more sources

Suppression of myoclonus in SCA2 by piracetam

open access: yesMovement Disorders, 2005
AbstractWe report on a 30‐year‐old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12–18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations ...
DE ROSA, ANNA   +8 more
openaire   +6 more sources

The action of piracetam in ischaemic flaps

open access: yesBritish Journal of Plastic Surgery, 1987
The effects of piracetam on skin flap viability, capillary blood flow and temperature were studied in abdominal cutaneous flaps in rats. The drug significantly increased the viability of the distal (random) portion of the flap and this response was dose-related.
D, Rossillon   +4 more
openaire   +3 more sources

Greenness Evaluation of Piracetam Detection Through Spectrofluorimetric Method With Shilajit-Derived Metal Oxide Nanosensors. [PDF]

open access: yesInt J Anal Chem
Piracetam (PRM) is a nootropic commonly used to improve cognitive function, memory, and learning ability. This method introduces a new spectrofluorimetric strategy for the identification of PRM, using metal oxide nanomaterials from Shilajit extract in a micellar medium.
Al-Shalawi AF   +3 more
europepmc   +2 more sources

The comparison of levetiracetam and piracetam effectiveness on breath-holding spells in children: A randomized controlled clinical trial

open access: yesAdvanced Biomedical Research, 2021
Background: We aimed to compare the effectiveness of Levetiracetam and Piracetam on the severity and frequency of spells in children with severe breath-holding spells (BHS), i.e.
Mohammad Reza Ghazavi   +5 more
doaj   +1 more source

Piracetam-induced neuroprotection in lipopolysaccharides-challenged EOC-20 cells and mouse brain via attenuating oxidative stress

open access: yes, 2022
Therapeutically, piracetam has been used for decades as a cognitive enhancer for memory- related neuronal disorders. The present study aimed to investigate the neuroprotective potential of piracetam on lipopolysaccharides (LPS)-induced neuronal deficit ...
Vasudevan Mani (6627356)
core   +1 more source

Home - About - Disclaimer - Privacy